10.01.18
Aptar Pharma executives will be delivering three Pharma Insight Briefings outlining the latest trends, technology and product innovations:
“Debunking the leachable myths of gamma sterilization: A migration study of steam vs gamma”
Julie D. Suman, R.Ph., Ph.D., President of Next Breath, a division of Aptar Pharma, Tuesday, October 9, 11:50 a.m. - 12:20 p.m.
Julie Suman will present a migration study commissioned by Aptar Pharma to assess the impact of both steam sterilization and gamma sterilization on leachable profiles.
“Portable care for your respiratory tract: Exploring new technology platforms”
Guenter Nadler, Director Business Development, Aptar Pharma, Tuesday, October 9, 12:30 p.m. - 1:00 p.m.
Guenter Nadler will discuss new trends in treating upper respiratory tract issues naturally, including new respiratory technology platforms that will meet new market needs.
“Building a connected devices eco-system for digital medicines”
Sai Shankar, Director Business Development, Aptar Pharma, Wednesday, October 10, 1:50 p.m. - 2:20 p.m.
Sai Shankar will highlight the need for a digital medicine eco-system to ensure connected devices are fully optimized through patient-centric design, secure data collection and management, and cross-platform interoperability.
“Debunking the leachable myths of gamma sterilization: A migration study of steam vs gamma”
Julie D. Suman, R.Ph., Ph.D., President of Next Breath, a division of Aptar Pharma, Tuesday, October 9, 11:50 a.m. - 12:20 p.m.
Julie Suman will present a migration study commissioned by Aptar Pharma to assess the impact of both steam sterilization and gamma sterilization on leachable profiles.
“Portable care for your respiratory tract: Exploring new technology platforms”
Guenter Nadler, Director Business Development, Aptar Pharma, Tuesday, October 9, 12:30 p.m. - 1:00 p.m.
Guenter Nadler will discuss new trends in treating upper respiratory tract issues naturally, including new respiratory technology platforms that will meet new market needs.
“Building a connected devices eco-system for digital medicines”
Sai Shankar, Director Business Development, Aptar Pharma, Wednesday, October 10, 1:50 p.m. - 2:20 p.m.
Sai Shankar will highlight the need for a digital medicine eco-system to ensure connected devices are fully optimized through patient-centric design, secure data collection and management, and cross-platform interoperability.
